Last reviewed · How we verify
i.v. sodium bicarbonate — Competitive Intelligence Brief
phase 3
Buffer / alkalinizing agent
Critical Care / Emergency Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
i.v. sodium bicarbonate (i.v. sodium bicarbonate) — G. d'Annunzio University. Intravenous sodium bicarbonate raises blood pH and alkalinity to counteract metabolic acidosis and improve systemic acid-base balance.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| i.v. sodium bicarbonate TARGET | i.v. sodium bicarbonate | G. d'Annunzio University | phase 3 | Buffer / alkalinizing agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Buffer / alkalinizing agent class)
- G. d'Annunzio University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- i.v. sodium bicarbonate CI watch — RSS
- i.v. sodium bicarbonate CI watch — Atom
- i.v. sodium bicarbonate CI watch — JSON
- i.v. sodium bicarbonate alone — RSS
- Whole Buffer / alkalinizing agent class — RSS
Cite this brief
Drug Landscape (2026). i.v. sodium bicarbonate — Competitive Intelligence Brief. https://druglandscape.com/ci/i-v-sodium-bicarbonate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab